Session Details
[3AS-07]【J】Modulation of Cell Fate Conversion in approaches from Biological Disorders
Fri. Nov 29, 2024 9:00 AM - 11:15 AM JST
Fri. Nov 29, 2024 12:00 AM - 2:15 AM UTC
Fri. Nov 29, 2024 12:00 AM - 2:15 AM UTC
Room 7(Fukuoka International Congress Center, 4F 413)
Organizer: Masahito Matsumoto (Juntendo University)
Developmental differentiation, disease progression and healing, and the acquisition of plasticity can be understood as cell fate conversion. The dynamic conversion of cellular states and functions in biological phenomena have been revealed by the progress of research on cell fate conversion, and is expected to lead to the development of first-in-class or best-in-class drug discovery for various diseases. In this symposium, we will discuss "Modulation of Cell Fate Conversion" from various perspectives including gene expression, cell differentiation, metabolism, cell reprogramming, and regenerative medicine, with "Cell Fate Conversion'' as a key word. We hope that this will serve as an opportunity for the development of a new cross-disciplinary fusion beyond the conventional framework.
Introduction
[3AS-07-01]Development of a new myocardial regeneration method targeting fibrosis
○masaki ieda1 (1. Keio University School of Medicine)
[3AS-07-02(3P-589)]Differences of developmental origin between neural crest and non-neural crest-derived cellswith fate-determining mechanisms of constituting the cardiopharyngeal region
○Akiyasu Iwase1,2,3, Yasunobu Uchijima1, Daiki Seya1, Mayuko Kida1, Hiroki Higashiyama1, Kazuhiro Matsui1, Akashi Taguchi2, Shogo Yamamoto4, Shiro Fukuda4, Seitaro Nomura5, Takahide Kohro6, Chisa Shukunami7, Haruhiko Akiyama8, Masahide Seki9, Akinori Kanai9, Yutaka Suzuki9, Yukihiro Harada10, Teruhisa Kuwamura10, Osamu Nakagawa10,11, Youichiro Wada2, Hiroyuki Aburatani4, Yukiko Kurihara1,2,12, Sachirko Miyagawa-Tomita1,13, Hiroki Kurihara1,2,3 (1. Dept. of Phys. chem. and Metab., Grad. Sch. of Med., Univ. of Tokyo, 2. ISC, Univ. of Tokyo, 3. IRCMS, Kumamoto Univ., 4. Genome Sci. Div., RCAST, Univ. of Tokyo, 5. Dept. of Card. Med., Grad. Sch. of Med., Univ. of Tokyo, 6. Dept. of Clin. Info., Jichi Med Univ, 7. Dept. of Mol. Bio. and Biochem., Grad. Sch. of Biomed. and Health Sci. Hiroshima Univ, 8. Dept. of Orthop. Surg., Gifu Univ., 9. Dept. of. Med. Genome. Sci., Grad. Sch. of Front Sci., Univ. of Tokyo, 10. Dept. of Biomed. Sci., Col. of Life Sci., Ritsumeikan Univ., 11. Dept. of Genom. Med., Res. Inst., NCVC, 12. Kagawa Nutrit. Univ., 13. Dept. of Animal Health Tech., Yamazaki Univ. Animal Health Tech)
[3AS-07-03(3P-566)]Understanding ES cell characteristics by integrating single-colony proteomics and quantitative analysis of colony images
○Ayaka Kakihara1, Atsushi Hatano1, Masaki Matsumoto1 (1. Dept. Omics Sys. Biol., Grad. Sch. Med. Dent. Sci., Niigata Univ.)
[3AS-07-04]Data-driven investigation of cell fate regulatory system via in silico gene perturbation
○Kenji Kamimoto1,2 (1. Research Institute for Microbial Diseases, Osaka University, 2. Osaka University’s Premium Research Institute for Human Metaverse Medicine)
[3AS-07-05(3P-735)]TNF family cytokine RANKL and CD40L signaling maintain medullary thymic epithelial cells in the adult thymus
○Mio Hayama1,2, Taishin Akiyama1,2 (1. RIKEN Center for Integrative Medical Sciences, 2. Graduate School of Medical Life Science, Yokohama City University)
[3AS-07-06]Development of Cell Fate Conversion Technology towards Severe Diabetes
○Masahito Matsumoto1,2 (1. Juntendo Univ., 2. Junten Univ.)
[3AS-07-07(3P-578)]Nutrient-dependent dedifferentiation in the intestinal epithelium promotes adaptive growth in Drosophila
Hiroki Nagai1,3, Luis Augusto Eijy Ngai2, Ryuichiro Nakato2, Masayuki Miura1, ○Yuichiro Nakajima1 (1. Grad Sch Pharm Sci, Univ. Tokyo, Japan, 2. IQB, Univ. Tokyo, Japan, 3. ISTA, Austria)
[3AS-07-08]Progress in direct reprogramming research and its medical prospects
○Atsushi Suzuki1 (1. Kyushu Univ.)